Circulating microRNAs as stable blood-based markers for cancer detection.
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of storage and freeze-thaw cycling of EDTA-plasma, and use of serum rather than EDTA-plasma on levels of MiRNA in specimens from healthy individuals. The effects of nuclease digestion on isolated miRNA were also investigated. The effect of room temperature storage was investigated using fresh plasma, but all other specimens were frozen at -80 degrees C until experimental freeze-thaw cycling or analysis. miRNA was isolated using mirVana kit and quantified by TaqMan real-time PCR.
Summary of Findings
91 known miRNAs were identified in plasma, and, as expected, were susceptible to RNAse treatment, but not DNAse treatment. Storage of plasma for up to 24 h at room temperature or 8 freeze-thaw cycles did not affect levels of miR-15b, miR-16, or miR-24. Further, the authors show that plasma levels of miR-15b, miR-16, and miR-24 were strongly correlated with serum levels, but actual R values were not reported.
Biospecimens
FluidPlasmaFluidSerumPreservation Types
None (Fresh)FrozenDiagnoses
NormalPlatforms
RNADNA sequencingRNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Storage Freeze/thaw cycling 1 cycle2 cycles4 cycles8 cyclesStorage Time at room temperature 0.5 h1 h2 h24 h4 h8 hReal-time qRT-PCR Specific Targeted nucleic acid miR-15bmiR-16miR-24